168 related articles for article (PubMed ID: 33092755)
41. Increased rates of atrial fibrillation recurrence following pulmonary vein isolation in overweight and obese patients.
Sivasambu B; Balouch MA; Zghaib T; Bajwa RJ; Chrispin J; Berger RD; Ashikaga H; Nazarian S; Marine JE; Calkins H; Spragg DD
J Cardiovasc Electrophysiol; 2018 Feb; 29(2):239-245. PubMed ID: 29131442
[TBL] [Abstract][Full Text] [Related]
42. Resistin as a Biomarker for the Prediction of Left Atrial Substrate and Recurrence in Patients with Drug-Refractory Atrial Fibrillation Undergoing Catheter Ablation.
Chang TY; Hsiao YW; Guo SM; Chang SL; Lin YJ; Lo LW; Hu YF; Chung FP; Chao TF; Liao JN; Tuan TC; Lin CY; Higa S; Chen SA
Int Heart J; 2020 May; 61(3):517-523. PubMed ID: 32418972
[TBL] [Abstract][Full Text] [Related]
43. The association between non-alcoholic fatty liver disease and atrial fibrillation: A meta-analysis.
Wijarnpreecha K; Boonpheng B; Thongprayoon C; Jaruvongvanich V; Ungprasert P
Clin Res Hepatol Gastroenterol; 2017 Oct; 41(5):525-532. PubMed ID: 28866089
[TBL] [Abstract][Full Text] [Related]
44. The association of baseline left atrial structure and function measured with cardiac magnetic resonance and pulmonary vein isolation outcome in patients with drug-refractory atrial fibrillation.
Habibi M; Lima JAC; Gucuk Ipek E; Zimmerman SL; Zipunnikov V; Spragg D; Ashikaga H; Rickard J; Marine JE; Berger RD; Calkins H; Nazarian S
Heart Rhythm; 2016 May; 13(5):1037-1044. PubMed ID: 26775143
[TBL] [Abstract][Full Text] [Related]
45. Association between nonalcoholic fatty liver disease and atrial fibrillation and other clinical outcomes: a meta-analysis.
Jaiswal V; Ang SP; Huang H; Momi NK; Hameed M; Naz S; Batra N; Ishak A; Doshi N; Gera A; Sharath M; Waleed MS; Raj N; Aguilera Alvarez VH
J Investig Med; 2023 Aug; 71(6):591-602. PubMed ID: 37002665
[TBL] [Abstract][Full Text] [Related]
46. Association between non-alcoholic fatty liver disease and risk of new-onset atrial fibrillation in healthy adults.
Roh JH; Lee JH; Lee H; Yoon YH; Kim M; Kim YG; Park GM; Park JH; Seong IW
Liver Int; 2020 Feb; 40(2):338-346. PubMed ID: 31479572
[TBL] [Abstract][Full Text] [Related]
47. Left atrial fibrosis progression detected by LGE-MRI after ablation of atrial fibrillation.
Kheirkhahan M; Baher A; Goldooz M; Kholmovski EG; Morris AK; Csecs I; Chelu MG; Wilson BD; Marrouche NF
Pacing Clin Electrophysiol; 2020 Apr; 43(4):402-411. PubMed ID: 31867751
[TBL] [Abstract][Full Text] [Related]
48. Early pulmonary vein reconnection as a predictor of left atrial ablation outcomes for paroxysmal atrial fibrillation.
Efremidis M; Letsas K; Giannopoulos G; Lioni L; Vlachos K; Asvestas D; Karlis D; Kareliotis V; Geladari H; Sideris A; Deftereos S
Europace; 2015 May; 17(5):741-6. PubMed ID: 25687747
[TBL] [Abstract][Full Text] [Related]
49. Correlation between the triglyceride-glucose index and the onset of atrial fibrillation in patients with non-alcoholic fatty liver disease.
Zhang Y; Wang L; Qi J; Yu B; Zhao J; Pang L; Zhang W; Bin L
Diabetol Metab Syndr; 2023 May; 15(1):94. PubMed ID: 37158953
[TBL] [Abstract][Full Text] [Related]
50. Renal function and outcomes after catheter ablation of patients with atrial fibrillation: The Guangzhou atrial fibrillation ablation registry.
Deng H; Shantsila A; Xue Y; Bai Y; Guo P; Potpara TS; Zhan X; Fang X; Liao H; Wu S; Lip GYH
Arch Cardiovasc Dis; 2019; 112(6-7):420-429. PubMed ID: 31133543
[TBL] [Abstract][Full Text] [Related]
51. Pulmonary Vein Antral Isolation and Nonpulmonary Vein Trigger Ablation Are Sufficient to Achieve Favorable Long-Term Outcomes Including Transformation to Paroxysmal Arrhythmias in Patients With Persistent and Long-Standing Persistent Atrial Fibrillation.
Liang JJ; Elafros MA; Muser D; Pathak RK; Santangeli P; Zado ES; Frankel DS; Supple GE; Schaller RD; Deo R; Garcia FC; Lin D; Hutchinson MD; Riley MP; Callans DJ; Marchlinski FE; Dixit S
Circ Arrhythm Electrophysiol; 2016 Nov; 9(11):. PubMed ID: 27784738
[TBL] [Abstract][Full Text] [Related]
52. Long-term influence of body mass index on cardiovascular events after atrial fibrillation ablation.
Bunch TJ; May HT; Bair TL; Crandall BG; Cutler MJ; Jacobs V; Mallender C; Muhlestein JB; Osborn JS; Weiss JP; Day JD
J Interv Card Electrophysiol; 2016 Sep; 46(3):259-65. PubMed ID: 27207256
[TBL] [Abstract][Full Text] [Related]
53. The incremental benefit of non-pulmonary vein left atrial ablation in patients undergoing a repeat persistent atrial fibrillation ablation procedure.
Goldenberg GR; Ono M; Aryana A; d'Avila A; Saad EB; Singh SK; Singh SM
J Interv Card Electrophysiol; 2017 Mar; 48(2):185-191. PubMed ID: 27766514
[TBL] [Abstract][Full Text] [Related]
54. Long-term efficacy and safety of adjunctive ethanol infusion into the vein of Marshall during catheter ablation for nonparoxysmal atrial fibrillation.
Liu CM; Lo LW; Lin YJ; Lin CY; Chang SL; Chung FP; Chao TF; Hu YF; Tuan TC; Liao JN; Chen YY; Kuo L; Chang TY; Hoang QM; Salim S; Vicera JJB; Wu CI; Chuang CM; Huang TC; Chen SA
J Cardiovasc Electrophysiol; 2019 Aug; 30(8):1215-1228. PubMed ID: 31148287
[TBL] [Abstract][Full Text] [Related]
55. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.
Letsas KP; Efremidis M; Giannopoulos G; Deftereos S; Lioni L; Korantzopoulos P; Vlachos K; Xydonas S; Kossyvakis C; Sideris A
Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452
[TBL] [Abstract][Full Text] [Related]
56. Incidence and significance of early recurrences of atrial fibrillation after cryoballoon ablation: insights from the multicenter Sustained Treatment of Paroxysmal Atrial Fibrillation (STOP AF) Trial.
Andrade JG; Khairy P; Macle L; Packer DL; Lehmann JW; Holcomb RG; Ruskin JN; Dubuc M
Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):69-75. PubMed ID: 24446022
[TBL] [Abstract][Full Text] [Related]
57. Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction in Patients With Nonalcoholic Fatty Liver Disease.
Packer M
Am J Med; 2020 Feb; 133(2):170-177. PubMed ID: 31622581
[TBL] [Abstract][Full Text] [Related]
58. Impact of CARDIOrespiratory FITness on Arrhythmia Recurrence in Obese Individuals With Atrial Fibrillation: The CARDIO-FIT Study.
Pathak RK; Elliott A; Middeldorp ME; Meredith M; Mehta AB; Mahajan R; Hendriks JM; Twomey D; Kalman JM; Abhayaratna WP; Lau DH; Sanders P
J Am Coll Cardiol; 2015 Sep; 66(9):985-96. PubMed ID: 26113406
[TBL] [Abstract][Full Text] [Related]
59. Electrophysiological and clinical characteristics of catheter ablation for isolated left side atrial tachycardia over a 10-year period.
Vicera JJB; Lin YJ; Lin CY; Lu DY; Chang SL; Lo LW; Chung FP; Chao TF; Hu YF; Tuan TC; Liao JN; Chen YY; Sukardi R; Salim S; Wu CI; Liu CM; Hoang QM; Ba VV; Huang TC; Chuang CM; Chen CC; Chin CG; Kuo L; Chen SA
J Cardiovasc Electrophysiol; 2019 Jul; 30(7):1013-1025. PubMed ID: 30977218
[TBL] [Abstract][Full Text] [Related]
60. Liver Disease as a Predictor of New-Onset Atrial Fibrillation.
Huang WA; Dunipace EA; Sorg JM; Vaseghi M
J Am Heart Assoc; 2018 Aug; 7(15):e008703. PubMed ID: 30371253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
